Healthcare company DexCom, Inc. (NASDAQ: DXCM) reported a double-digit increase in second-quarter earnings and also provided full-year guidance.
- Second-quarter revenue grew 25% year-over-year to $871.3 million, on a reported basis, and 26% on an organic basis
- U.S. revenue rose 21%; international revenue increased 38% on a reported basis and 40% on an organic basis
- Operating income increased sharply to $128.1 million in Q2 from $77.0 million in the prior-year quarter
- Q2 net income was $115.9 million or $0.28 per share, compared to $50.9 million or $0.12 per share in the same quarter of 2022
- As of June 30, Dexcom held $3.64 billion in cash, cash equivalents, and marketable securities
- For fiscal 2023, the management expects total revenue to be in the range of $3.500 billion to 3.550 billion, which represents a 20-22% growth
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q3 2024
Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to
Key highlights from Exxon Mobil Corporation’s (XOM) Q3 2024 earnings results
Exxon Mobil Corporation (NYSE: XOM) reported its third quarter 2024 earnings results today. Total revenues and other income remained relatively flat at $90 billion compared to the same period a
AAPL Earnings: Apple Q4 2024 sales rise 6% YoY, beat estimates
Apple Inc. (NASDAQ: AAPL) reported an increase in revenues for the fourth quarter of 2024. The top line came in above estimates. The gadget giant generated revenues of $94.9 billion